Difficult questions a person with dementia might ask and how to respond Asking for a partner, friend or relative who has died. If they are asking for a partner, relative or friend who has died, ...

Sue Noakes has young-onset Alzheimer's disease and shares how counselling and continuing with mindful hobbies helped ...

Dementia changed our dad and our lives. Life for dad got harder day by day. He could sense his confusion and told us that he hated it. His diagnosis forced him to stop driving, and he was very sad as ...

Read more about how the arts can help people living with dementia. James Pickett, Head of Research at Alzheimer's Society, discusses how the arts can help people living with dementia. Art and culture ...

With the cost of dementia expected to rise to £90 billion by 2040, and the number of people living with the condition predicted to rise to 1.4 million in the same time frame, Alzheimer’s Society are ...

Today, Monday 2 June, Alzheimer’s Society has released a new photography series to launch its 2025 Forget Me Not Appeal which aims to end the devastation caused by dementia – the UK’s biggest killer, ...

The insurance industry unites against dementia. The award-winning Insurance United Against Dementia (IUAD) campaign has announced the appointment of Chris Lay, CEO of Marsh McLennan UK, as its new ...

Today, Wednesday 11th June 2025, the Government delivered their Spending Review, providing insight into the UK Government's plans for spending and investment until 2029-30.

Today, Monday 2 June, Alzheimer’s Society has released a new photography series to launch its 2025 Forget Me Not Appeal which aims to end the devastation caused by dementia – the UK’s biggest killer, ...

Jacquelyn was 57 when she was diagnosed with early-onset Alzheimer’s disease. Here, her daughter Laury describes the dementia journey in detail – from spotting the early signs, to the final stages – ...

Donanemab has been licensed in the UK as a treatment for early-stage Alzheimer’s but is only available privately, not through the NHS. Here's what we know about this new Alzheimer's drug.